{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:43:25Z","timestamp":1794408205596,"version":"4.9.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative condition that primarily affects motor functions; it is caused by the loss of midbrain dopaminergic (mDA) neurons. The therapeutic effects of transplanting human-induced pluripotent stem cell (iPSC)-derived mDA neural progenitor cells in animal PD models are known and are being evaluated in an ongoing clinical trial. However, However, improvements in the safety and efficiency of differentiation-inducing methods are crucial for providing a larger scale of cell therapy studies. This study aimed to investigate the usefulness of dopaminergic progenitor cells derived from human iPSCs by our previously reported method, which promotes differentiation and neuronal maturation by treating iPSCs with three inhibitors at the start of induction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Healthy subject-derived iPS cells were induced into mDA progenitor cells by the CTraS-mediated method we previously reported, and their proprieties and dopaminergic differentiation efficiency were examined <jats:italic>in vitro<\/jats:italic>. Then, the induced mDA progenitors were transplanted into 6-hydroxydopamine-lesioned PD model mice, and their efficacy in improving motor function, cell viability, and differentiation ability in vivo was evaluated for 16 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Approximately \u226580% of cells induced by this method without sorting expressed mDA progenitor markers and differentiated primarily into A9 dopaminergic neurons in vitro. After transplantation in 6-hydroxydopamine-lesioned PD model mice, more than 90% of the engrafted cells differentiated into the lineage of mDA neurons, and approximately 15% developed into mature mDA neurons without tumour formation. The grafted PD model mice also demonstrated significantly improved motor functions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study suggests that the differentiation protocol for the preparation of mDA progenitors is a promising option for cell therapy in patients with PD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2023.1202027","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T22:44:00Z","timestamp":1689201840000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Ryota","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genko","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maierdanjiang","family":"Nuermaimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wado","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei-ichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1523\/JNEUROSCI.21-20-08108.2001","article-title":"Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease","volume":"21","author":"Akerud","year":"2001","journal-title":"J. Neurosci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.expneurol.2007.10.012","article-title":"Characterization of the striatal 6-Ohda model of Parkinson's disease in wild type and alpha-synuclein-deleted mice","volume":"210","author":"Alvarez-Fischer","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1242\/dev.097394","article-title":"How to make a midbrain dopaminergic neuron","volume":"142","author":"Arenas","year":"2015","journal-title":"Development"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nrneurol.2015.123","article-title":"Cell-based therapies for Parkinson disease-past insights and future potential","volume":"11","author":"Barker","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.stem.2010.07.003","article-title":"Graft-induced dyskinesias in Parkinson's disease: what is it all about?","volume":"7","author":"Barker","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","article-title":"Human trials of stem cell-derived dopamine neurons for Parkinson's disease: dawn of a new era","volume":"21","author":"Barker","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"14845","DOI":"10.1073\/pnas.1009874107","article-title":"Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors","volume":"107","author":"Bateup","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.nbd.2016.06.005","article-title":"Dramatic differences in susceptibility to L-dopa-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion","volume":"94","author":"Bez","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00243848","article-title":"Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease","volume":"65","author":"Brundin","year":"1986","journal-title":"Exp. Brain Res."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"E1946","DOI":"10.1073\/pnas.1501989112","article-title":"Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors","volume":"112","author":"Bye","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"De Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat. Commun."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","article-title":"Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation","volume":"2","author":"Doi","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.stem.2010.03.001","article-title":"Efficient derivation of functional floor plate tissue from human embryonic stem cells","volume":"6","author":"Fasano","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1038\/s41467-021-27464-5","article-title":"Single-cell transcriptomics captures features of human midbrain development and dopamine neuron diversity in brain organoids","volume":"12","author":"Fiorenzano","year":"2021","journal-title":"Nat. Commun."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.stemcr.2017.09.024","article-title":"Escape from pluripotency via inhibition of TGF-Beta\/BMP and activation of Wnt signaling accelerates differentiation and aging in hPSC progeny cells","volume":"9","author":"Fujimori","year":"2017","journal-title":"Stem Cell Reports"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1111\/j.1460-9568.2010.07265.x","article-title":"Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease","volume":"31","author":"Grealish","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jcyt.2015.02.001","article-title":"Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease","volume":"17","author":"Han","year":"2015","journal-title":"Cytotherapy"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1093\/hmg\/ddz241","article-title":"Mutations in CHCHD2 cause alpha-synuclein aggregation","volume":"28","author":"Ikeda","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.stemcr.2015.10.005","article-title":"Controlling the regional identity of hPSC-derived neurons to uncover neuronal subtype specificity of neurological disease phenotypes","volume":"5","author":"Imaizumi","year":"2015","journal-title":"Stem Cell Reports"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/7651_2017_10","article-title":"Assessment of mitophagy in iPS cell-derived neurons","volume":"1759","author":"Ishikawa","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e9575","DOI":"10.15252\/emmm.201809575","article-title":"Cellular, molecular, and clinical mechanisms of action of deep brain stimulation-a systematic review on established indications and outlook on future developments","volume":"11","author":"Jakobs","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","article-title":"Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports","volume":"71","author":"Kefalopoulou","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1016\/j.stem.2021.01.005","article-title":"Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use","volume":"28","author":"Kim","year":"2021","journal-title":"Cell Stem Cell"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.celrep.2012.04.009","article-title":"Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions","volume":"1","author":"Kirkeby","year":"2012","journal-title":"Cell Rep."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.25378","article-title":"Developing dopaminergic cell therapy for Parkinson's disease-give up or move forward?","volume":"28","author":"Lindvall","year":"2013","journal-title":"Mov. Disord."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","article-title":"Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up","volume":"46","author":"Lindvall","year":"1989","journal-title":"Arch. Neurol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-dopa-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.stemcr.2016.01.010","article-title":"Functional neurons generated from T cell-derived induced pluripotent stem cells for neurological disease modeling","volume":"6","author":"Matsumoto","year":"2016","journal-title":"Stem Cell Reports"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1038\/nprot.2017.078","article-title":"Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation","volume":"12","author":"Nolbrant","year":"2017","journal-title":"Nat. Protoc."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/brain\/awaa064","article-title":"Variants in saposin D domain of prosaposin gene linked to Parkinson's disease","volume":"143","author":"Oji","year":"2020","journal-title":"Brain"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/ejn.14109","article-title":"Cell-based therapy for Parkinson's disease: a journey through decades toward the light side of the force","volume":"49","author":"Parmar","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1016\/j.stem.2021.01.004","article-title":"Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01","volume":"28","author":"Piao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/16060","article-title":"Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient","volume":"2","author":"Piccini","year":"1999","journal-title":"Nat. Neurosci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"38ra46","DOI":"10.1126\/scitranslmed.3000976","article-title":"Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants","volume":"2","author":"Politis","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"13097","DOI":"10.1038\/ncomms13097","article-title":"Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1","volume":"7","author":"Samata","year":"2016","journal-title":"Nat. Commun."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1093\/hmg\/ddx201","article-title":"Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson's disease","volume":"26","author":"Shiba-Fukushima","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.baga.2012.01.002","article-title":"Anatomy of graft-induced dyskinesias: circuit remodeling in the parkinsonian striatum","volume":"2","author":"Steece-Collier","year":"2012","journal-title":"Basal Ganglia"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3124","article-title":"Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model","volume":"33","author":"Steinbeck","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbrc.2016.12.188","article-title":"Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons","volume":"483","author":"Suzuki","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","article-title":"iPS cell-based therapy for Parkinson's disease: a Kyoto trial","volume":"13","author":"Takahashi","year":"2020","journal-title":"Regen Ther."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cells"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1038\/s41467-020-16225-5","article-title":"Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson's disease","volume":"11","author":"Tiklova","year":"2020","journal-title":"Nat. Commun."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e156768","DOI":"10.1172\/JCI156768","article-title":"Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson's disease model","volume":"132","author":"Xu","year":"2022","journal-title":"J. Clin. Invest."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.stemcr.2020.04.011","article-title":"Identifying therapeutic agents for amelioration of mitochondrial clearance disorder in neurons of familial Parkinson disease","volume":"14","author":"Yamaguchi","year":"2020","journal-title":"Stem Cell Reports"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.276.5310.248","article-title":"Dopamine neuron agenesis in Nurr1-deficient mice","volume":"276","author":"Zetterstrom","year":"1997","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/stem.2616","article-title":"Intrastriatal transplantation of human neural stem cells restores the impaired subventricular zone in parkinsonian mice","volume":"35","author":"Zuo","year":"2017","journal-title":"Stem Cells"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1202027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T22:44:05Z","timestamp":1689201845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1202027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":56,"alternative-id":["10.3389\/fnins.2023.1202027"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1202027","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2023.1202027.s001","asserted-by":"subject"}]},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"article-number":"1202027"}}